Targeting the IL-17 pathway in inflammatory disorders / Cong-Qiu Chu.
By: Chu, Cong-Qiu., autor
Material type:
E-bookPublisher: Cham, Switzerland : Adis, 2017Description: 1 recurso en línea.ISBN: 3319280406; 9783319280400.Subject: Inflamación
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | QR185.8.I56 C483 2017 EB (Browse shelf(Opens below)) | Acceso electrónico | eBook.20022592 |
Browsing Madrid Digital shelves, Shelving location: Acceso Electrónico (UEM) Close shelf browser (Hides shelf browser)
| QR185.8 .F33 F37 2014 EB Fc Receptors | QR185.8.G4 2017 EB Germinal Centers Methods and Protocols | QR185.8 .I56 2001 EB Interleukin Protocols | QR185.8.I56 C483 2017 EB Targeting the IL-17 pathway in inflammatory disorders | QR185.8 .I56 I58 2014 EB Interleukin-10 in Health and Disease | QR185.8.I56 J365 2016 EB Interleukin-27: Biological Properties and Clinical Application | QR185.8.I56 L37 2016 EB Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology |
Incluye referencias bibliográficas
Introduction -- Overview of IL-17 family.-Il-17 in host defense -- Th17 cells: differentiation and regulation -- The role of the IL-17/Th17 pathway in the pathogenesis of autoimmune inflammatory diseases -- Therapeutic applications: strategies and molecules targeting the IL-17/Th17 pathway -- Concluding remarks.
This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.
There are no comments on this title.